Status:
COMPLETED
Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo
Lead Sponsor:
Oslo University Hospital
Conditions:
Vitiligo
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
BACKGROUND Vitiligo is a common, often distressing condition. Many of the patients do not achieve sufficient effect from what is regarded as the treatment of choice at present, narrow band(NB)UVB(Tl01...
Eligibility Criteria
Inclusion
- Patients aged at least 18 years with a stable, symmetric vitiligo
Exclusion
- Patients with segmental vitiligo, aged \< 18 years, known hypersensitivity to Tacrolimus, pregnant or breastfeeding women
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
End Date :
January 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00807690
Start Date
November 1 2005
End Date
January 1 2008
Last Update
December 12 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.